Intuitive Surgical ISRG
$452.80 −$15.72 (-3.36%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $453.85 +0.23%
Open$457.00
Prev close$468.52
Day range$450.51 – $463.25
Volume2.15M
Market cap$156.96B
P/E (TTM)54.8
Dividend yield–
ISRG Stock News
Headlines matching Intuitive Surgical or the ISRG ticker, most recent first.
- BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
- BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
- BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $469
- BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
- TD Cowen Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $485
- Piper Sandler Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
- Intuitive Surgical(ISRG.US) Director Sells US$4 Million in Common Stock
- Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $500
- Oppenheimer Upgrades Intuitive Surgical(ISRG.US) to Buy Rating, Announces Target Price $500 Positive
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Legend Biotech (LEGN) and Mineralys Therapeutics, Inc. (MLYS)
- Bernstein Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $685
- HSBC Initiates Intuitive Surgical(ISRG.US) With Hold Rating, Announces Target Price $391
- BMO Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $518
- UBS Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Cuts Target Price to $500 Negative
- Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $487
No comments yet — be the first to weigh in on ISRG.